AstraZeneca PLC

$78.58 0.06%
NASDAQ: AZN
Market Cap.: 243.6 B XL
P/E: 38.15 x9.78
EPS: 2.06 x 2.98
Earnings Call
1 month, 3 weeks from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield: 2.15%
Payout: 75.25%
Volume Level
μ 4,447,496
2,607,051 Moderate Low
Performance Ranks (Intraday)
United Kingdom:

268th

out of

851

Healthcare:

310th

out of

792

Drug Manufacturers—General:

17th

out of

62

Peer Group:

3rd

out of

9

About

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, …